Late-onset MS patients are more likely to accumulate disability through mechanisms not directly linked to relapses, per a ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated. To ...

Relapsed multiple myeloma is cancer that returns after a period of remission. Refractory multiple myeloma is myeloma that does not respond to treatment. Your treatment options and outlook can vary ...

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of ...

Patient factors, including prior therapies, aggressiveness of relapse, comorbidities, and access to care, are important considerations in the choice of therapy for relapsed multiple myeloma. The ...

As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immune-mediated graft-versus-leukemia effect. We ...

(Barcelona, Spain, Wednesday, 24 September 2025) New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ...